Rare diseases
Investigational molecules
Locations
Georgy Sofiiski Str 1, 1431 Sofia, Bulgaria
Diagnostic-consultative center “Aleksandrovska” EOOD in Sofia, Bulgaria specialises in clinical trials of conditions such as Asthma, Dermatitis atopic, Chronic spontaneous urticaria, Obesity, and other specialisations. This site conducts important research.
Clinical research at Diagnostic-consultative center “Aleksandrovska” EOOD includes studies in Digestive System Diseases, with a strong focus on Crohn's disease. These trials are designed to evaluate new treatment options and better understand how therapies may improve disease control and intestinal health.
The site is contributing to research that aims to improve care for people living with chronic digestive inflammation and to support more effective long-term management strategies.
Another key area of work is Immune System Diseases, especially chronic spontaneous urticaria. The trials here are focused on evaluating whether new treatments can reduce symptoms such as hives and itch while also examining safety and overall tolerability.
These studies help advance care for patients whose immune-related symptoms can be persistent and difficult to manage.
Research in Skin and Connective Tissue Diseases at the Sofia site overlaps with immune-mediated skin disorders, particularly chronic spontaneous urticaria. The clinical trials are aimed at improving diagnostic understanding and testing whether new therapies can provide better relief from visible and uncomfortable skin symptoms.
With multiple investigators involved, the center is helping expand research options for patients affected by ongoing skin and connective tissue disease symptoms.
Clinical trials currently enrolling participants at this site.
BI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
BulgariaA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
BulgariaA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
BulgariaA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
BulgariaA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
BulgariaA study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)
BulgariaA Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy
BulgariaStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
BulgariaStudy of SPN-817 (Huperzine A) in Adults with Focal Onset Seizures: Testing Safety and Effectiveness of Treatment
BulgariaStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
BulgariaLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
BulgariaStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
BulgariaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
